Prostate cancer is a type of cancer which is slow-growing and treatable. Also, early detection can prevent progression. However, early prostate cancer presents no symptoms in the body. Therefore, doctors advise attending regular testing to ensure proper detection. Furthermore, hormones act as a primary source of this cancer. Also, it can help the cancer in replication and division.
What is prostate cancer?
Prostate cancer is known as the abnormal growth of cells in the walnut-sized prostate gland located below the bladder. In addition, this cancer is the most common type in men. In addition, there are some factors which can influence the growth of this prostate cancer. Also, it can include age, family history, genetics and race.
What are the symptoms of prostate cancer?
In early stages, prostate cancer does not have any symptoms. Moreover, when symptoms start appearing, it is due to the tumor increasing. Also, sometimes the tumor can press towards the urethra and affect overall function.
Common symptoms
- Frequent Urination
- Trouble getting the urine stream started
- Weak Flow
- Incomplete Emptying
- Sudden urges to urinate
- Painful sensation
Serious symptoms
- Blood in urine
- Bone & Joint Pain
- Erectile Dysfunction
- Weight Loss & Fatigue
Understanding the Role of Hormones in Prostate Cancer
Hormones are the body’s chemical messengers which are produced by various glands. Furthermore, it travels through the bloodstream to act on specific organs and tissues. Thus, enhancing body processes such as growth, mood, metabolism, and reproduction. Also, hormones like testosterone aid in the growth of prostate cancer cells. Moreover, hormones can help in cancer growth, progression, and division.
Apalutamide for Advanced Prostate Cancer
This medicine is an oral anti-androgen targeted therapy. Moreover, it blocks androgens from binding to receptors. Therefore, it can block the cancer cells from growth signals. In addition, it can cause the cancer to starve and die finally.
What are the brands?
- ERLEADA 60mg
- PROSTAXEN 60mg
What are the benefits?
- Delay disease progression
- Decrease cancer load
- Reduce cancer spread
- Lower tumor size
What are the side effects?
The side effects are as follows:
Common side effects
- Fatigue
- Tiredness
- Pain
- Diarrhea
- Nausea
- Rashes
- Dryness
- Redness
- High blood pressure
- Hot flashes
- Weight loss
Serious side effects
- Heart Attack
- Skin Reactions
- Seizures
- Fractures
- Lung Problems
Abiraterone for Prostate Cancer
Doctors give the medicine as targeted hormone therapy. Furthermore, it works by blocking the production of testosterone. Also, these hormones help cancer cells to grow and develop. Moreover, it can decrease cancer load and spread in the body.
What are the brands?
- ABIRACINE 250mg
- ABIRAPRO 250mg
- ZYTIGA 250mg
What are the benefits?
- Prevent producing testosterone
- Reduces tumor burden
- Stops cancer growth
- Decrease cancer progression
- Limit tumor size
What are the side effects?
The side effects are as follows:
Common side effects
- Joint swelling
- Muscle aches
- Diarrhea
- Nausea
- Vomiting
- Tiredness
- Weakness
- Hot flashes
- Coughing
- Fluid retention
Serious side effects
- Liver Problems
- Heart issues
- Adrenal lack
- Low Blood Sugar
Enzalutamide for Hormone-Sensitive and Castration-Resistant Prostate Cancer
The medicine works as an androgen receptor inhibitor. Furthermore, it blocks androgen receptors from binding to cancer cells. Also, it inhibits the receptors from entering the nucleus. Therefore, this action led to the stoppage of the receptor binding with DNA. Moreover, the cancer cells were unable to replicate and spread inside the body.
What is the brand?
What are the benefits?
- Prolongs overall survival
- Delay cancer spread
- Decrease cancer load
- Reduce cancer progression
- Lowers tumor size
What are the side effects?
The side effects are as follows:
Common side effects
- Fatigue
- Tiredness
- Pain
- Hot Flashes
- Joint pain
- Diarrhea
- Headaches
- Dizziness
- High Blood Pressure
Serious side effects
- Seizures
- Heart Problems
- Bone Fractures
- Posterior Reversible Encephalopathy Syndrome
- Severe Allergic Reactions
- Choking Hazard
How do these treatments differ?
These treatments can have different actions towards prostate cancer. There are key differences, like:
- Abiraterone works to decrease hormone production. Also, it stops the body from making androgens.
- Apalutamide and Enzalutamide prevent cancer cells from binding to androgens
- Enzalutamide blocks the signaling inside the cell after testosterone binds.
What are the future treatments in prostate cancer?
The future of prostate cancer is focusing on precision medicine. Moreover, doctors try to lower the side effects. Therefore, there are specific treatments, like the following:
- PSMA-PET Scans
- Targeted Radiation
- Next-Gen Isotopes
- AI-Assisted Robotics
- Specific Antibodies
Conclusion
Prostate cancer develops only in the prostate gland, which is the part of the male reproductive system. Moreover, the symptoms can arise when the tumor affects the urinary system. Therefore, doctors suggest doing regular monitoring and tests to detect it early. On the other hand, hormones in the body regulate and enhance the cancer cells. So, patients rely on medicines to stop cancer growth. There are multiple modern therapies to reduce cancer progression.
FAQs
Why is prostate cancer medicine not prescribed for women?
Women do not have a prostate gland because it is a part of the male reproductive system. Furthermore, if given, women can undergo side effects and hormonal changes.
What is the need for hormone-based treatments?
This can help in treating prostate cancer because it relies on male hormones. Also, it targets testosterone for their growth.
References
- Rawla, P. (2019). Epidemiology of prostate cancer. World journal of oncology, 10(2), 63. https://pmc.ncbi.nlm.nih.gov/articles/PMC6497009/
- Raychaudhuri, R., Lin, D. W., & Montgomery, R. B. (2025). Prostate cancer: a review. Jama, 333(16), 1433-1446. https://jamanetwork.com/journals/jama/article-abstract/2831269
- Denmeade, S. R., & Isaacs, J. T. (2002). A history of prostate cancer treatment. Nature Reviews Cancer, 2(5), 389-396. https://www.nature.com/articles/nrc801
- Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., & Mashele, S. (2022). Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules, 27(17), 5730. https://www.mdpi.com/1420-3049/27/17/5730
- Teo, M. Y., Rathkopf, D. E., & Kantoff, P. (2019). Treatment of advanced prostate cancer. Annual review of medicine, 70(1), 479-499. https://www.annualreviews.org/content/journals/10.1146/annurev-med-051517-011947
